| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.38 | 0.008 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.44 | 0.008 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |